JP5647111B2 - トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド - Google Patents

トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド Download PDF

Info

Publication number
JP5647111B2
JP5647111B2 JP2011513436A JP2011513436A JP5647111B2 JP 5647111 B2 JP5647111 B2 JP 5647111B2 JP 2011513436 A JP2011513436 A JP 2011513436A JP 2011513436 A JP2011513436 A JP 2011513436A JP 5647111 B2 JP5647111 B2 JP 5647111B2
Authority
JP
Japan
Prior art keywords
phage
virus
peptide
avian influenza
aiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011513436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522561A (ja
JP2011522561A5 (cg-RX-API-DMAC7.html
Inventor
ユソッフ、カティジャ、モド
オマル、アブドゥル、ラマン
イデリス、アイニ
ラジク、モハメッド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiti Putra Malaysia (UPM)
Original Assignee
Universiti Putra Malaysia (UPM)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiti Putra Malaysia (UPM) filed Critical Universiti Putra Malaysia (UPM)
Publication of JP2011522561A publication Critical patent/JP2011522561A/ja
Publication of JP2011522561A5 publication Critical patent/JP2011522561A5/ja
Application granted granted Critical
Publication of JP5647111B2 publication Critical patent/JP5647111B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C07K16/108—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011513436A 2008-06-12 2009-06-10 トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド Expired - Fee Related JP5647111B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MYPI20082061A MY160435A (en) 2008-06-12 2008-06-12 A novel antiviral peptide against avian influenza virus h9n2
MYPI20082061 2008-06-12
PCT/MY2009/000071 WO2009151313A1 (en) 2008-06-12 2009-06-10 A novel antiviral peptide against avian influenza virus h9n2

Publications (3)

Publication Number Publication Date
JP2011522561A JP2011522561A (ja) 2011-08-04
JP2011522561A5 JP2011522561A5 (cg-RX-API-DMAC7.html) 2012-07-19
JP5647111B2 true JP5647111B2 (ja) 2014-12-24

Family

ID=41416902

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011513436A Expired - Fee Related JP5647111B2 (ja) 2008-06-12 2009-06-10 トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド

Country Status (6)

Country Link
US (1) US8883480B2 (cg-RX-API-DMAC7.html)
EP (1) EP2300492B1 (cg-RX-API-DMAC7.html)
JP (1) JP5647111B2 (cg-RX-API-DMAC7.html)
DK (1) DK2300492T3 (cg-RX-API-DMAC7.html)
MY (1) MY160435A (cg-RX-API-DMAC7.html)
WO (1) WO2009151313A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12013500204A1 (en) 2010-08-03 2013-04-01 Univ Washington Through Its Center For Commercialization Polypeptides for treating and/or limiting influenza infection
CN102830225B (zh) * 2012-09-24 2014-06-04 中国动物疫病预防控制中心 一种源于禽流感病毒自然弱毒株的血凝素和免疫抗原
MY184269A (en) * 2015-11-27 2021-03-30 Viramatix Sdn Bhd Broad-spectrum anti-influenza virus therapeutic peptides
MX2019013874A (es) 2017-05-26 2020-07-28 Viramatix Sdn Bhd Peptidos y sus usos como agentes antivirales.
EP3837275A4 (en) 2018-06-29 2022-07-13 Fred Hutchinson Cancer Center BAR CODED DEEP MUTATION SCAN LIBRARIES STORED IN A CELL, AND USES OF SUCH LIBRARIES
CN109628641B (zh) * 2019-01-07 2022-03-01 广西壮族自治区兽医研究所 用于检测h7以及5个na亚型aiv的引物组合及其应用
CN109487012B (zh) * 2019-01-07 2020-09-22 广西壮族自治区兽医研究所 用于检测9个na亚型aiv的引物组合及其应用
CN109487011B (zh) * 2019-01-07 2022-03-01 广西壮族自治区兽医研究所 用于检测h5、h7和h9以及9个na亚型aiv的引物组合及其应用
US11821111B2 (en) 2019-11-15 2023-11-21 Fred Hutchinson Cancer Center Barcoded influenza viruses and deep mutational scanning libraries including the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
CA2323064C (en) * 1998-03-17 2011-05-31 Gendaq Limited Nucleic acid binding proteins
CA2365575A1 (en) * 1999-03-31 2000-10-12 Otsuka Pharmaceutical Co., Ltd. Influenza virus hemagglutinin-binding peptides
WO2003006620A2 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US7888121B2 (en) * 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US20080008725A1 (en) * 2005-08-16 2008-01-10 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine
CA2649261A1 (en) * 2006-03-13 2007-09-20 Keio University Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent
EP2046806A4 (en) * 2006-07-05 2009-10-21 Scripps Research Inst CHIMERIC RECOMBINASES WITH ZINC FINGERS OPTIMIZED FOR CATALYSIS BY DIRECT EVOLUTION
US8778847B2 (en) 2007-06-13 2014-07-15 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Immunogenic peptides of influenza virus
ES2609818T3 (es) * 2007-06-15 2017-04-24 Xiamen University Anticuerpos monoclonales que se unen a hemaglutinina del virus de la gripe aviar del subtipo H5 y usos de los mismos

Also Published As

Publication number Publication date
JP2011522561A (ja) 2011-08-04
WO2009151313A1 (en) 2009-12-17
US20110135676A1 (en) 2011-06-09
US8883480B2 (en) 2014-11-11
DK2300492T3 (da) 2014-09-01
EP2300492B1 (en) 2014-06-04
MY160435A (en) 2017-03-15
EP2300492A1 (en) 2011-03-30
EP2300492A4 (en) 2012-03-14

Similar Documents

Publication Publication Date Title
JP5647111B2 (ja) トリインフルエンザウイルスｈ９ｎ２に対する新規な抗ウイルスペプチド
Leneva et al. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol
Rajik et al. Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2
CN101848719B (zh) 流感抑制组合物和方法
US8796008B2 (en) Influenza A virus vaccines and inhibitors
US20130205416A1 (en) Anti-viral agent
CN102791734A (zh) 源自人b细胞且具有抗甲型流感病毒的中和活性的人单克隆抗体
Ramanujam et al. Novel peptides that inhibit the propagation of Newcastle disease virus
JP2011522561A5 (cg-RX-API-DMAC7.html)
Russell et al. Influenza glycoproteins: Hemagglutinin and neuraminidase
WO2013082531A2 (en) Broad spectrum influenza a neutralizing vaccines and d-peptidic compounds, and methods for making and using the same
Arbi et al. Inhibition of avian influenza virus H9N2 infection by antiviral hexapeptides that target viral attachment to epithelial cells
Chung et al. Preventive and therapeutic effects of a super-multivalent sialylated filamentous bacteriophage against the influenza virus
US20230059521A1 (en) Methods of treating or preventing a viral infection using bacteriophages
Chia et al. Structural analysis of peptides that interact with Newcastle disease virus
CN103965292B (zh) 乙型脑炎病毒包膜蛋白结合肽的结构与用途
CN111393512B (zh) 一种抑制流感病毒的多肽及其在制备预防和治疗流感病毒感染药物中的应用
EP4674984A1 (en) Compositions
Rajik et al. Novel Anti-viral Peptide Against Avian Infl uenza Virus H9N2
KR20250106189A (ko) 재조합 박테리오파지를 포함하는 인간 코로나바이러스 oc43 또는 인플루엔자 a 바이러스 감염증 예방 또는 치료용 약학 조성물
WO2008048306A2 (en) Influenza a virus vaccines and inhibitors
Jarmołowicz Small molecules interacting with Influenza virus RNA and SARS-CoV-2 RNA as potential inhibitors of replication
CN120424203A (zh) 抗h5亚型禽流感病毒纳米抗体及其构建方法和用途
CN116763902A (zh) 抗冠状病毒脂肽在治疗和预防流行性感冒中的用途
Arnold et al. Influenza A virus vaccines and inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120601

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120601

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140317

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140416

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141016

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141106

R150 Certificate of patent or registration of utility model

Ref document number: 5647111

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees